Ayurveda’s Real Contribution to India’s Healthcare

The Bed That Wasn’t There

The Post That Made Me Stop Scrolling

A few days ago, a LinkedIn post caught my attention — and I suspect it caught the attention of many others in Indian healthcare. Pratap Dusi, Head of Marketing at ISB and a senior voice in healthcare communications, shared a map of India annotated with a single, damning metric: public hospital beds per 1000 population across Indian states.

The numbers from MoHFW’s Health Dynamics of India 2022–23 were stark. India has 0.6 public hospital beds per 1000 population. Even after factoring in private healthcare infrastructure, that number rises only to approximately 1.3 per 1000 — still less than half the WHO-recommended 3 beds per 1000. The disparity across states is equally disturbing: Chandigarh leads at 3.50, Puducherry at 3.60, Lakshadweep at 3.62, while Bihar trails at 0.55, alongside Manipur and Mizoram. Karnataka, where I practise, sits at a middling 0.80.

Dusi closed with a line that stayed with me: “India cannot solve a 21st-century healthcare burden with 20th-century infrastructure.”

He is right. But his post — and the crisis it describes — immediately raised a question that neither he nor his followers had cause to ask, but that we in Ayurveda are obligated to: Where does Ayurveda stand in this picture? What beds does our system contribute? What crisis does our system address? And are we being honest about the difference between what we claim and what we deliver?

This article is my attempt to answer those questions — with data, not devotion.

I. Setting the Stage: India’s Hospital Bed Crisis

Let us begin with what Dusi’s post established, because the numbers deserve to sit on the page without softening.

Table 1: Public Hospital Beds per 1000 Population — Selected Indian States (MoHFW, HDI 2022–23)

State/UT Beds per 1000
Lakshadweep 3.62
Puducherry 3.60
Chandigarh 3.50
Goa 3.20
Delhi 3.20
Andaman & Nicobar Islands 3.00
Kerala 1.19
Tamil Nadu 1.07
West Bengal 0.80
Karnataka 0.80
Maharashtra 0.80
Rajasthan 0.82
Gujarat 0.75
Andhra Pradesh 0.75
Telangana 0.75
Uttar Pradesh 0.60
Madhya Pradesh 0.60
Odisha 0.60
Assam 0.60
Himachal Pradesh 0.65
J & K 0.65
Punjab 0.70
Haryana 0.70
Sikkim 0.60
Jharkhand 0.60
Chhattisgarh 0.60
Bihar 0.55
Manipur 0.55
Nagaland 0.55
Mizoram 0.55
India (National Average — Public) ~0.60
India (Including Private) ~1.30

Source: MoHFW, Health Dynamics of India 2022–23; as cited in Pratap Dusi’s LinkedIn post, May 2026

The total public bed count, according to a Parliament statement in March 2026 citing HDI 2022–23 data, stands at 8,18,661 beds across Primary Health Centres, Community Health Centres, Sub-District Hospitals, District Hospitals, and Medical Colleges combined.

For a country of 1.4 billion people, this is not a shortfall. It is a structural emergency.

Now. Into this emergency, let us introduce Ayurveda — and ask the question honestly.

II. Ayurveda’s Infrastructure Footprint: The Actual Numbers

The Ministry of Ayush publishes annual figures on hospitals, dispensaries, beds, and registered practitioners. Here is what the most recent data tells us.

Table 2: AYUSH Healthcare Infrastructure — National Snapshot (2023–24)

Parameter Total Government Sector
AYUSH Hospitals 3,844 3,403
Hospital Beds (all AYUSH systems) 60,943 (majority government)
AYUSH Dispensaries 36,848 27,118
Registered AYUSH Practitioners 7,51,768 —

Sources: Ministry of Ayush Annual Report 2023–24; Indian Public Health Standards for Ayush Hospitals 2024; Business Standard, December 2024; Parliament Statement, March 2025

Let us now do the arithmetic that the Ministry of Ayush’s press releases conspicuously avoid doing.

Table 3: AYUSH vs. Allopathic Public Bed Capacity — Comparative Analysis

System Total Beds Beds per 1000 Population (India, 1.4 bn)
Allopathic Public Sector (PHC to Medical College) 8,18,661 ~0.58
All AYUSH Systems Combined (all 3,844 hospitals) 60,943 ~0.043
Ayurveda alone (estimated majority share of AYUSH beds) Not separately published <0.030 estimated
WHO Recommended — 3.00
India Total (Public + Private Allopathy) — ~1.30

The entire AYUSH hospital bed stock — across Ayurveda, Homeopathy, Unani, Siddha, Naturopathy, and Yoga combined — amounts to approximately 7.4% of the already catastrophically inadequate public allopathic bed count.

On a per-1000 basis, AYUSH beds contribute 0.043 beds per 1000 — roughly thirteen times fewer than the allopathic public sector’s already crisis-level figure.

This is the bed that wasn’t there.

And I ask — not rhetorically, but with genuine professional urgency — why is no one in the Ayurvedic establishment leading with this number?

III. The Best-Case Scenario: What Kerala Tells Us

Kerala is routinely — and justifiably — cited as the most developed model of Ayurvedic public healthcare delivery in India. If we want to understand what Ayurveda’s inpatient footprint looks like when it is taken seriously by a state government, Kerala is our benchmark.

The numbers, from a 2021 peer-reviewed study on Kerala’s COVID-19 Ayurvedic response:

  • 947 public Ayurvedic healthcare facilities in Kerala
  • 130 public Ayurvedic hospitals providing inpatient services
  • 3,154 inpatient beds in the public Ayurvedic system
  • Approximately 1,500 Ayurvedic doctors in the public system

The same study noted, with admirable candour: “In comparison with the conventional health system, the Ayurveda Department does not have as many resources, either on the manpower front or the infrastructure front. On account of these constraints, the service delivery system in the Ayurveda side of public health was not as extensive as the general health system.”

This is Kerala. The state with the highest Human Development Index in India. The state where Ayurveda has had centuries of institutional continuity. The state where the government has invested the most. And even here, the Ayurvedic inpatient system is explicitly acknowledged to be structurally inadequate compared to the allopathic public system.

If Kerala is our best case, what does the rest of India look like?

IV. The Usage Statistics: Reading Between the Headlines

This is where the analysis becomes most important — and most easily misread. The Government of India, through the NSSO, conducted the country’s first exclusive all-India AYUSH survey as part of its 79th Round (July 2022 to June 2023), covering 1,81,298 households.

The headline findings, as released by PIB in June 2024, were these:

Table 4: NSSO 79th Round — Key AYUSH Usage Findings

Finding Rural Urban
Persons aware of AYUSH 95% 96%
Persons who used AYUSH in last 365 days 46.3% 52.9%
Of these, specifically used Ayurveda 40.5% 45.5%
Average annual spend on Ayurveda (per person) ₹394 ₹499
Primary purpose of AYUSH use Rejuvenation/Prevention Rejuvenation/Prevention

Source: PIB Press Release No. 2025076, Ministry of Statistics & Programme Implementation, June 2024

These numbers have been quoted — often triumphantly — to claim that nearly half of India uses Ayurveda. Let me be direct: that claim requires serious qualification.

The NSSO defined “use of Ayush” to include:

  • Home-based remedies and self-medication
  • Use of medicinal plants at home
  • Awareness and application of folk medicine and local health traditions
  • Consultation with registered or unregistered practitioners

Turmeric milk administered to a child with a cold qualifies. Applying neem paste to a skin rash qualifies. Drinking kadha during a fever qualifies. A visit to a local herbal practitioner who may hold no formal qualification qualifies.

This is not a criticism of home-based Ayurvedic practice — it is enormously valuable. But it is not the same as institutional Ayurvedic healthcare delivery. When we use these numbers to claim that Ayurveda is a functioning public healthcare system at scale, we are conflating two fundamentally different things: a cultural health tradition and a structured healthcare delivery system.

The average annual expenditure — ₹394 per person rurally and ₹499 in urban areas — makes this point more precisely than any argument I can construct. Less than ₹500 per year per person does not describe institutional clinical care.

Now compare this with the NSS 71st Round (2014) data, subjected to rigorous utilisation analysis:

  • Only 6.9% of all outpatient-seeking patients used AYUSH services
  • Use of AYUSH for inpatient, hospital-based care was so low it was excluded from the analysis entirely
  • AYUSH outpatient use was concentrated among patients with chronic diseases, skin disorders, and musculoskeletal ailments

Between 2014 and 2022–23, outpatient AYUSH awareness and use has grown substantially. The inpatient story has not changed.

V. The Conditions Served: Where Ayurveda Genuinely Contributes

I want to be precise here, because honesty runs in both directions. Ayurveda’s dismissal by biomedical absolutists is as intellectually dishonest as Ayurveda’s overclaiming by promotional absolutists.

Table 5: Conditions Where Evidence-Based Ayurvedic Practice Has Documented Contribution

Condition Category Level of Evidence / Nature of Contribution
Chronic musculoskeletal disorders (osteoarthritis, low back pain, Pakshaghata) Moderate — multiple RCTs, significant OPD utilisation
Skin disorders (psoriasis, chronic eczema, urticaria) Moderate — documented in clinical practice, some RCT evidence
Metabolic and lifestyle disorders (type 2 diabetes adjunct, obesity) Moderate — Ayurvedic interventions as adjunct, not replacement
Neurological rehabilitation (post-stroke, Parkinson’s adjunct) Emerging — Panchakarma-based protocols, pilot evidence
Mental health and psychosomatic conditions (anxiety, insomnia, stress) Moderate — integrative models gaining traction
Reproductive health (fertility, PCOS, gynaecological disorders) Moderate — evidence base growing
Preventive and promotive health (Rasayana, Ritucharya, seasonal care) Strong conceptual basis, limited RCT evidence by design
Rejuvenation and wellness (Panchakarma) Substantial private sector delivery; limited public health evidence

Table 6: Conditions Entirely Beyond Ayurvedic Institutional Capacity

Condition Category Reason
Acute cardiac emergencies (MI, heart failure, arrhythmia) Requires ICU, catheterisation, pharmacological precision
Acute stroke (ischaemic/haemorrhagic) Requires CT imaging, thrombolytics, neurosurgical backup
Polytrauma and surgical emergencies No surgical tradition in contemporary Ayurvedic practice
Sepsis and acute infectious disease Requires IV antibiotics, critical care monitoring
Neonatal emergencies, NICU care No institutional NICU in Ayurvedic hospitals
Cancer treatment (curative intent) Surgery, chemotherapy, radiotherapy are outside scope
Organ failure requiring dialysis or transplant No Ayurvedic equivalent exists

The acute care categories in Table 6 are precisely the conditions that drive India’s hospital bed demand. They are the reason patients queue at district hospitals. They are the reason Bihar’s 0.55 beds per 1000 is a death sentence for some of its citizens. And they are, categorically, beyond Ayurveda’s institutional delivery capacity — not because Ayurveda is worthless, but because these conditions require a different class of infrastructure, technology, and pharmacological precision.

A 2023 paper in AYUHOM making the case for mainstreaming Ayurveda explicitly acknowledged: “Although the AYUSH system is not equipped to handle cases of acute medical and surgical emergency, it has solutions for most health problems.” This is Ayurveda’s own scholarship speaking. We should be listening.

VI. The Market Illusion: $43 Billion and 60,943 Beds

The AYUSH market grew from $2.85 billion in 2014 to $43.4 billion in 2023. Exports doubled from $1.09 billion to $2.16 billion. These figures were cited with evident pride by the Ministry of Ayush in December 2024.

Yet the total bed count across all 3,844 AYUSH hospitals stands at 60,943.

A $43.4 billion economy. 60,943 beds. I want the reader — particularly the Ayurvedic professional — to sit with this for a moment.

The reason is straightforward. The AYUSH market is predominantly not a healthcare delivery market. It is a consumer goods market. Patanjali’s atta noodles count in the AYUSH economy. Himalaya’s moisturiser counts. Kerala’s Panchakarma tourism counts. These are not irrelevant — they represent cultural capital, rural employment, foreign exchange — but they are not hospital beds. They do not reduce maternal mortality. They do not treat the stroke patient in rural Bihar.

Every time we cite $43 billion while silently omitting 60,943 beds, we are choosing comfortable optics over honest reckoning.

VII. The Co-location Strategy: Integration or Illusion?

The Government of India’s primary mechanism for integrating Ayurveda into public healthcare is co-location — placing AYUSH units within existing PHCs, CHCs, and District Hospitals under the National Ayush Mission (NAM).

But what does co-location actually deliver? Co-located AYUSH facilities are, in the vast majority of cases, dispensary-level, outpatient, medication-dispensing points. They do not add hospital beds. They do not provide emergency services. They do not reduce the pressure on the district hospital’s inpatient wards.

A CAG audit report (Report No. 10 of 2025) on AYUSH in Uttar Pradesh found: delays in completion of sanctioned AYUSH hospitals; hospitals lacking basic facilities; funds parked in bank accounts without utilisation for patient welfare; and sites selected without proper care. This is not exceptional — it is symptomatic of a programme that moves faster in announcements than in delivery.

The co-location strategy, at its best, places an Ayurvedic practitioner within an accessible public facility — providing culturally acceptable, low-cost first contact for patients with chronic and mild conditions. This is worth acknowledging. But it does not address the bed deficit, the emergency gap, the surgical backlog, or the ICU shortage that Pratap Dusi’s map is screaming about.

VIII. The Integrative Hospital Push: Promise, Politics, or Policy?

The Ministry of Ayush has significantly amplified its rhetoric and policy movement towards integrative medicine — presenting the convergence of Ayurveda and modern medicine as a solution to India’s healthcare challenge. Let us examine what has been announced, what is operational, and what it means in practice.

What Has Been Announced

March 2024: Ministers Sonowal and Mandaviya jointly announced the AYUSH-ICMR Advanced Centre for Integrative Health Research (AI-ACIHR) at select AIIMS, alongside a multicentre clinical trial on Anaemia and Indian Public Health Standards for AYUSH.

2024–25: Integrated Ayush Departments have been established at Vardhman Mahavir Medical College & Safdarjung Hospital and at Lady Hardinge Medical College, New Delhi — through AIIA.

National Ayurveda Day 2025: A Tripartite MOU on Integrative Oncology was signed between AIIA, Ministry of Ayush, and Tata Hospital. An Integrative Oncology Unit was opened at AIIA Goa.

December 2025 / Budget 2026: Three new All India Institutes of Ayurveda announced. The CARI Rohini campus — a ₹187 crore, 2.92-acre facility — was foundation-stoned by PM Modi, with a 100-bed research hospital included in plans.

May 2025: Ministry of Ayush and WHO signed an MoU on a Traditional Medicine module in the International Classification of Health Interventions (ICHI), backed by India’s ₹26 crore contribution.

Budget 2026: Five Regional Medical Tourism Hubs in partnership with the private sector, integrating Ayush, modern medicine, education, and research.

Table 7: Key Integrative Medicine Initiatives — Ministry of Ayush, 2024–2026

Initiative Year Nature Bed/Capacity Addition
AYUSH-ICMR Centre (AI-ACIHR) at AIIMS 2024 Research + clinical integration Research-oriented; not direct bed addition
Dept. of Integrative Medicine, Safdarjung + LHMC 2024 OPD-level integration in allopathic hospital No new beds
AIIA Goa — Integrative Oncology Unit 2025 Specialised clinical unit Limited bed addition
Tripartite MOU: AIIA-Ayush-Tata Hospital 2025 Research and care collaboration Oncology-specific
CARI Rohini, Delhi 2025 (foundation) Research hospital 100 beds (when complete)
3 New All India Institutes of Ayurveda 2026 (Budget) Education + hospital Unspecified; future
5 Regional Medical Tourism Hubs 2026 (Budget) Integrative health + tourism Primarily private sector
WHO Global TM Centre, Jamnagar (upgrade) 2026 Research; global standards No clinical beds

Sources: PIB March 2025; Agro Spectrum India December 2025; NewsonAir March 2026; NewKerala.com February 2026

Five Questions the Integrative Push Must Answer

First — Does integration add beds? Looking at Table 7 carefully: the only concrete bed addition in the entire 2024–2026 integrative push is the 100-bed CARI research hospital in Rohini — not yet complete, and primarily a research hospital. Every other initiative is OPD-level integration, research collaboration, or tourism infrastructure. The bed deficit does not move.

Second — Is this a healthcare strategy or a diplomatic one? The WHO MoU, the Germany JWG collaboration, the BRICS summit statements, the Ayush Mark for global certification, the medical tourism hubs — these serve India’s health diplomacy agenda well. But health diplomacy and domestic healthcare delivery are different things. Bihar’s 0.55 beds per 1000 is not addressed by India’s leadership of the WHO Global Traditional Medicine Centre in Jamnagar.

Third — What does integration look like at the PHC level, where the population actually is? All flagship integrative initiatives are at tertiary institutions — AIIMS, Safdarjung, LHMC, AIIA Goa, Tata Hospital. The rural PHC continues to receive co-located AYUSH dispensary units — not integrative hospitals.

Fourth — Is private sector integration serving patients or positioning India as a wellness tourism destination? Budget 2026’s explicit framing of the five Regional Hubs around “medical tourism” is telling. This is legitimate as an industry strategy. It does not serve the patient in Bidar or Bellary.

Fifth — Is there an evidence base for the integrative protocols being deployed? Integrative oncology at Tata Hospital will presumably be evidence-supervised. The same cannot be assumed for a 50-bed Integrated Ayush Hospital in rural Haryana under the state’s 2025–26 plan.

The integrative direction is not wrong. The gap between the rhetoric and what it delivers at population scale deserves scrutiny that the Ayurvedic establishment is not providing.

IX. The Crosspathy Reality: The Practice We Do Not Talk About

This is the section that many colleagues will find uncomfortable. I write it anyway, because intellectual honesty is not selective.

There is a practice so widespread in Ayurvedic medicine in India that it has acquired its own name: crosspathy — AYUSH-qualified practitioners, including BAMS graduates, prescribing and administering allopathic drugs. Antibiotics. Steroids. NSAIDs. Antipyretics. Antihypertensives. Anti-diabetic drugs. In private clinics. In rural PHCs. In hospitals running under an Ayurvedic licence. Quietly, routinely, and — in most states — illegally.

The legal position is not ambiguous. The Supreme Court of India, in Dr. Mukhtiar Chand & Others vs. State of Punjab & Others (Civil Appeal No. 89 of 1987), established that AYUSH practitioners cannot prescribe allopathic drugs. The Court subsequently held a homoeopath liable for negligence — constituting medical negligence — after prescribing allopathic medicines led to a patient’s death. The NMC position is explicit: crosspathy is impermissible.

And yet.

A 2018 peer-reviewed paper examining allopathic, AYUSH, and informal practitioners in rural India stated directly: “Existing state policies that legitimise Allopathic practice by non-Allopathic practitioners do not help the rural poor to access proper medical treatment for acute conditions. Also, it does not enhance the credibility of the indigenous systems of medicine.”

Table 8: The Crosspathy Landscape — Legal Status, State Practice, and Healthcare Reality

Parameter Position
Supreme Court ruling AYUSH practitioners cannot prescribe allopathic drugs
NMC position Crosspathy impermissible; legal consequences for non-compliance
Formal legal status Illegal in general; permissible only where specifically authorised by State Government
Karnataka BAMS doctors in PHCs can practice modern medicine in emergencies
Maharashtra Homoeopathic doctors with pharmacology training can prescribe certain allopathic drugs
MP, Rajasthan, Bihar State provisions allow AYUSH doctors to prescribe in rural/primary settings
Estimated rural specialist shortage 80% — only 4,413 of 21,964 needed specialists available (RHS 2022-23)
Bridge Course status Proposed, strongly opposed, dropped
IMA concern Misuse of steroids and antibiotics already occurring; antibiotic resistance risk

Sources: IMA; ClearIAS; Drishti IAS; ScienceDirect 2018; The Federal, July 2025

Why This Belongs in This Article

The relevance of crosspathy to this article’s central argument is direct and uncomfortable.

If Ayurvedic practitioners — even in hospitals carrying the designation of “Ayurvedic hospitals” — are routinely managing fever, infection, pain, hypertension, and diabetes using allopathic protocols, then the following questions arise:

What exactly is Ayurveda’s contribution to the patients walking through those doors? Is it Ayurvedic medicine they are receiving, or is it modern medicine delivered by someone holding an Ayurvedic qualification?

When we cite Ayurvedic OPD numbers, what proportion of those consultations involved Ayurvedic pharmacopoeia versus allopathic prescriptions? This data is almost entirely absent from official reporting. Its absence is not accidental.

Does crosspathy validate Ayurveda’s capacity as a healthcare system, or does it reveal its limits? If an Ayurvedic practitioner reaches for metformin when a diabetic patient presents with fasting glucose of 280, or amoxicillin when a child presents with fever and a productive cough — they are not demonstrating Ayurvedic healthcare delivery. They are demonstrating that modern medicine is the default for acute conditions, even in Ayurvedic settings.

The Self-Implication

I say this as someone who runs an Ayurvedic teaching hospital and supervises Ayurvedic postgraduate training.

Our institutions need to be honest about what medicine is actually being practised within their walls. Our clinical records, our prescription audits, our discharge summaries — if examined rigorously — would tell a story more complex than “Ayurvedic hospital delivering Ayurvedic care.” In many cases, they would show a hybrid practice: Ayurvedic procedures coexisting with allopathic drug prescriptions for acute and emergency management.

The humanitarian case for this is not trivial. In a world where the MBBS doctor refuses rural Karnataka, the BAMS graduate who knows when to give a saline drip and when to refer may — as one commentator noted — be “better than no doctor at all.”

But we cannot simultaneously claim this as evidence of Ayurveda’s independent healthcare delivery capacity. We cannot count prescriptions of amoxicillin and paracetamol in the patient load of an “Ayurvedic” hospital and cite that load as proof that Ayurveda is serving India’s healthcare needs.

The honest framing is this: Ayurvedic practitioners are often filling a gap that the allopathic system has failed to fill — with a mixture of their own system’s tools and borrowed tools from a system they are not licensed to practise. That is a healthcare access story. A rural infrastructure story. A workforce deployment story. It is not, in the main, an Ayurveda-as-healthcare-system story.

Until we are honest about this distinction, we cannot have an honest conversation about what investments are needed, what training reforms are required, and what Ayurveda’s actual — as opposed to attributed — contribution to India’s healthcare is.

X. The Questions We Must Ask Ourselves

I have spent two decades inside Ayurvedic academia — as a student, a clinician, a researcher, a teacher, and now as an institution head. I say what follows from within, not from outside.

Do we know how many functioning inpatient Ayurvedic beds exist at this moment? Not sanctioned. Not approved. Not announced. Functioning — occupied, staffed, equipped, and delivering care to admitted patients right now.

When we cite NSSO’s “46% of Indians use AYUSH,” do we follow it with the ₹394 average annual spend? The two numbers must be read together. Ayurveda is deeply embedded in Indian households as a cultural health practice, not as an institutional healthcare system. Both are real. Both matter. They are not the same thing.

When we advocate for Ayurveda in public health, do we specify which roles we are advocating for? Chronic disease management, preventive care, first-contact primary care for non-acute conditions — these are legitimate, evidence-supported roles. Do we advocate for these specifically, or do we make undifferentiated claims implying Ayurveda can substitute for a district hospital?

Do we train our graduates to understand the limits of their system with the same rigour with which we train them to celebrate its strengths? A postgraduate Ayurvedic student in Kerala told Down to Earth in 2023: “Our curriculum does not explain exactly how Ayurveda applies to public health. We should be able to explain whether this is a complete system of medicine which can treat all types of diseases or whether it should be complementary to modern medicine. I am still not clear.” That student’s confusion is our failure, not theirs.

Are our teaching hospitals honest about their inpatient capacity, occupancy rates, and the range of conditions we actually manage at the bedside? Or do our prospectuses and accreditation submissions paint a picture that our daily ward rounds do not support?

XI. What Honest Contribution Looks Like

None of this analysis is an argument for Ayurveda’s irrelevance. It is an argument for Ayurveda’s clarity — about what it is, what it does well, and where it must acknowledge its limits.

Ayurveda genuinely contributes to:

  • Managing chronic, non-communicable disease burden — the largest and fastest-growing segment of India’s healthcare challenge
  • Providing culturally acceptable, cost-effective, accessible first-contact care for mild and moderate illness
  • Preventive and promotive health — where its conceptual framework (Dinacharya, Ritucharya, Rasayana) is genuinely ahead of biomedical thinking
  • Rehabilitation support for neurological conditions
  • Reducing out-of-pocket expenditure for long-term management of conditions where biomedical maintenance therapy is expensive

Where Ayurveda cannot contribute at current institutional scale:

  • Acute and emergency inpatient care
  • Surgical conditions
  • Critical care
  • The bed deficit that Pratap Dusi’s map is documenting

The honest path forward is integration based on demonstrated competence at each tier of care — not a generalised claim of equivalence with biomedicine across all clinical domains. Kerala shows us what this can look like at its best. But even Kerala’s own researchers tell us it is not enough, and it is not the same as what the allopathic public system provides.

XII. Conclusion: The Bed We Must Build — Honestly

India’s hospital bed crisis is real. Pratap Dusi, a marketing professional with no axe to grind in the AYUSH debate, put the numbers clearly and correctly on the table. Bihar’s 0.55 beds per 1000. India’s 0.6. The WHO’s 3.0. The gap is not a policy disagreement — it is a daily crisis for millions of Indians who cannot access inpatient care when they need it.

Ayurveda, with its 60,943 beds across all AYUSH systems combined — 0.043 per 1000 — does not solve this crisis. It barely registers in its arithmetic.

This is not Ayurveda’s shame. Ayurveda was not designed as an emergency inpatient system. Its strength has always been in its epistemology of prevention, its understanding of constitution, its long-term management of imbalance, its integration of mind and body in clinical reasoning. These are real strengths, and they are increasingly relevant to the chronic disease burden that will define India’s healthcare challenge in the coming decades.

But strengths require honest boundaries to be credible. A system that claims everything ends up being trusted for nothing.

The bed that wasn’t there — those 0.043 AYUSH beds per 1000 — is not a statistic to hide. It is a prompt for honest strategic thinking about where Ayurveda can contribute, where it cannot, and what kind of institutional investment it would take to make its contribution real rather than rhetorical.

If Ayurveda is serious about being a public healthcare system — not a wellness economy, not a cultural heritage programme, not a diplomatic soft-power tool, but an actual system of healthcare delivery for 1.4 billion people — then it must be prepared to be held to the same question Pratap Dusi asked of Indian healthcare writ large:

How many lives can we reach in time?

Until we can answer that with beds, with staffed hospitals, with emergency protocols, and with honest data — the bed that wasn’t there will remain the most important statistic in our story.

References

  1. MoHFW. Health Dynamics of India 2022–23 (Infrastructure & Human Resources). Ministry of Health and Family Welfare, GoI. [Cited in Pratap Dusi LinkedIn post, May 2026; Parliament Statement, Rajya Sabha, March 2026]

  2. Ministry of Statistics & Programme Implementation. Results of Survey on AYUSH (July 2022–June 2023) — 79th Round NSS. PIB Press Release No. 2025076. New Delhi, 13 June 2024. https://pib.gov.in/PressReleaseIframePage.aspx?PRID=2025076

  3. Ministry of Ayush, GoI. Annual Report 2023–24. https://ayush.gov.in/resources/pdf/annualReport/English-Annual-Report-12-Dec-2024.pdf

  4. Indian Public Health Standards (IPHS) for Ayush Hospitals 2024. Ministry of Ayush / NHM.

  5. Parliament of India, Rajya Sabha. Written Reply by MoS Health, Shri Prataprao Jadhav. March 2026. As reported in Medical Dialogues, 19 March 2026. https://medicaldialogues.in/amp/ayush/ayurveda/news/altogether-751768-ayush-doctors

  6. Business Standard. “AYUSH market grows from $2.85 bn in 2014 to $43.4 bn in 2023: Govt.” 2 December 2024. https://www.business-standard.com/health/ayush-market-grows-from-2-85-bn-in-2014-to-43-4-bn-in-2023-govt

  7. Sundararajan R, et al. Utilization of alternative systems of medicine as health care services in India: Evidence on AYUSH care from NSS 2014. PMC, 2017. [6.9% OPD utilisation; inpatient excluded]

  8. Gopakumar G, et al. Ayurvedic Response to COVID-19 Pandemic in Kerala, India. PMC, 2021. [Kerala: 947 facilities, 130 hospitals, 3,154 beds]

  9. Tripathi JS. Making Ayurveda a Dependable Health-care System in India. AYUHOM 10(2):61–67, Jul–Dec 2023. DOI: 10.4103/AYUHOM.AYUHOM_6_23.

  10. CAG of India. Report No. 10 of 2025: Performance Audit on AYUSH, Uttar Pradesh. New Delhi, 2025.

  11. Rao M, Pilot E. Is Ayurveda the key to universal healthcare in India? ResearchGate/BMC, 2014.

  12. Why knowing Ayurveda’s limitations and improving clinical exposure are important. Down to Earth, 22 March 2023.

  13. NSS 71st Round (2014), as analysed in: Utilization of alternative systems of medicine. PMC, 2017.

  14. Pratap Dusi. LinkedIn post on public hospital beds per 1000 population. May 2026. Source: MoHFW HDI 2022–23.

  15. PIB, GoI. “Ministry of Ayush has taken multiple initiatives towards integration of Ayush systems with Allopathic system.” 25 March 2025. https://www.pib.gov.in/PressReleasePage.aspx?PRID=2114965

  16. Agro Spectrum India. “Ministry of Ayush caps 2025 as breakthrough year.” 31 December 2025. https://agrospectrumindia.com/2025/12/31/ministry-of-ayush-caps-2025

  17. NewsonAir / GoI. “Three new All India Institutes of Ayurveda to be established.” 1 February 2026. https://www.newsonair.gov.in/three-new-all-india-institutes-of-ayurveda

  18. IBEF. “Ayush Industry in India: Growth, Market Size & Opportunities.” https://www.ibef.org/industry/ayush

  19. NewsonAir. “National Ayurveda Day 2025 — Tripartite MOU on Integrative Oncology.” September 2025. https://www.newsonair.gov.in/national-ayurveda-day-2025

  20. NewsonAir. “New Healthcare Facilities Inaugurated at AIIMS Ayurveda Campus in Goa.” 8 March 2026. https://www.newsonair.gov.in/new-healthcare-facilities-inaugurated

  21. Sundararajan R, et al. “Allopathic, AYUSH and informal medical practitioners in rural India — a prescription for change.” ScienceDirect, 2018. https://www.sciencedirect.com/science/article/pii/S0975947618303486

  22. ClearIAS. “Crosspathy.” January 2025. https://www.clearias.com/crosspathy/

  23. Drishti IAS. “Crosspathy.” https://www.drishtiias.com/daily-updates/daily-news-analysis/crosspathy

  24. The Federal. “Should homeopathy, ayurveda specialists be called ‘doctors’?” July 2025. https://thefederal.com/category/health/ayush-doctors-dr-title-crosspathy-debate-ima-nmc-197158

  25. IMA. Statement on AYUSH practitioners prescribing allopathic medicines. https://www.ima-india.org/ima/free-way-page.php?pid=199

  26. Rural Health Statistics 2022–23. MoHFW. [80% rural specialist shortage; 4,413 of 21,964 specialists available]

  27. Wikipedia / Careers360. “Bachelor of Ayurveda, Medicine and Surgery (BAMS).” [State-wise permissions on crosspathy]

  28. NewKerala.com. “Union Budget 2026 prioritizes Ayush as central pillar.” 2 February 2026. https://www.newkerala.com/news/a/union-budget-2026-prioritizes-ayush-as-central-pillar-539.htm

  29. NewsonAir. “Ayurveda, Yoga Key to Patient-Centric Healthcare: AYUSH Minister at BRICS Summit.” 29 August 2025. https://www.newsonair.gov.in/ayurveda-yoga-key-to-patient-centric-healthcare-ayush-minister-at-brics-summit

*Dr. Aakash Kembhavi, MD (Ayurveda), PGDMLS, MS (Counselling & Psychotherapy) writes at Ayurveda Unfiltered.

Views expressed are the author’s own. All data cited is from publicly available government sources and peer-reviewed literature.